Promoter methylation of genes in bronchial lavages: A marker for early diagnosis of primary and relapsing non-small cell lung cancer?
- 30 November 2005
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 50 (2) , 199-209
- https://doi.org/10.1016/j.lungcan.2005.05.019
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- 5′CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancerEuropean Journal Of Cancer, 2004
- Detection of Promoter Hypermethylation of Multiple Genes in the Tumor and Bronchoalveolar Lavage of Patients with Lung CancerClinical Cancer Research, 2004
- Aberrant methylation of the adenomatous polyposis coli promoter 1A in bronchial aspirates from patients with suspected lung cancerInternational Journal of Cancer, 2004
- Hypermethylation ofFHITas a prognostic marker in nonsmall cell lung carcinomaCancer, 2004
- Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokersInternational Journal of Cancer, 2003
- Early detection of lung cancer: role of biomarkersEuropean Respiratory Journal, 2003
- Molecular detection approaches for smoking associated tumorsOncogene, 2002
- DNA methylation analysis: a powerful new tool for lung cancer diagnosisOncogene, 2002
- Alterations of the p16ink4a gene in resected nonsmall cell lung tumors and exfoliated cells within sputumInternational Journal of Cancer, 2002
- Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinomaOncogene, 1999